tiprankstipranks
Innate Pharma (IPHA)
NASDAQ:IPHA
Want to see IPHA full AI Analyst Report?

Compare Innate Pharma (IPHA) vs. Competitors

133 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Innate Pharma
$1.66
$179.25M
-2.71
-16.06%
2 Buy
0 Hold
0 Sell
Moderate Buy
SELLAS Life Sciences Group
$4.11
$1.45B
-21.70
342.05%
2 Buy
0 Hold
0 Sell
Moderate Buy
Sangamo Therapeutics
$0.26
$72.22M
-0.78
-64.78%
1 Buy
1 Hold
0 Sell
Moderate Buy
Elicio Therapeutics
$13.55
$189.91M
-4.12
93.20%
4 Buy
0 Hold
0 Sell
Strong Buy
Vor Biopharma
$16.59
$776.48M
>-0.01
283.57%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IPHA
Innate Pharma
1.83
-0.33
-15.28%
SLS
SELLAS Life Sciences Group
7.78
5.89
311.64%
SGMO
Sangamo Therapeutics
0.17
-0.30
-63.21%
GNFT
ELTX
Elicio Therapeutics
9.95
4.29
75.80%
VOR
Vor Biopharma
14.33
10.86
312.97%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts